Skip to content
healthcare.dev

Pramipexole Dihydrochloride

NDC 50228-131, Pramipexole Dihydrochloride, tablet, from ScieGen Pharmaceuticals Inc.

Product NDC
50228-131
Status
Listed
Labeler
ScieGen Pharmaceuticals Inc
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203855
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50228-131 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PRAMIPEXOLE DIHYDROCHLORIDE1.5 mg/1

Pharmacologic classes

Dopamine Agonists [MoA]; Nonergot Dopamine Agonist [EPC]

Package NDCNDC-11Package
50228-131-10502280131101000 TABLET in 1 BOTTLE (50228-131-10)
50228-131-905022801319090 TABLET in 1 BOTTLE (50228-131-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/395fee34-43dc-4840-a6b8-70d5736f9c8b

Use it

Look up 50228-131 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50228-131 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50228-131. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.